On the inhibitory affect of some dementia drugs on DNA polymerase Beta activity

Neurochemical Research
V N VyjayantiKalluri Subba Rao

Abstract

Some drugs are routinely prescribed for dementia that sets in either due to normal ageing or due to neurodegenerative disorders. We have studied the effect of three of these drugs, Donepezil hydrochloride, Rivastigmine tartrate and Nootropyl, on the activity of DNA polymerases beta, a crucial enzyme in the base excision repair pathway, the most important mode of DNA repair in brain. All the three drugs inhibited DNA polymerase beta activity to varying degrees although the affects of Donepezil being the least and inconsistent. The drugs preferentially bind to and inhibit the activities of 8 kDa domain of DNA polymerase beta that is known to possess the dRP lyase activity. The function of 31 kDa domain dealing with template driven addition of nucleotides at 3' end of the primer is not adversely affected. The inhibitory action of most widely used dementia drugs on DNA repair potential signifies that pharma sector needs to consider this aspect especially while designing drugs targeted towards brain.

References

Jul 1, 1979·European Journal of Biochemistry·J WaserS Spadari
Oct 1, 1984·The Journal of Pharmacy and Pharmacology·M T Tacconi, R J Wurtman
Jan 1, 1983·Psychopharmacology·G ChouinardF Fontaine
May 1, 1994·Brain Research. Brain Research Reviews·A H Gouliaev, A Senning
Feb 1, 1993·Neurology·B CroisileM Billardon
Jul 8, 1998·Mutation Research·S H Wilson
Nov 26, 1998·Drugs & Aging·C M Spencer, S Noble
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Aug 18, 2000·Mutation Research·W A Beard, S H Wilson
Jun 26, 2001·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R MorettiG Cazzato
Mar 26, 2002·The Journal of Biological Chemistry·Maria J JezewskaWlodzimierz Bujalowski
Oct 24, 2002·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·N S RajiKalluri Subba Rao
Sep 24, 2004·Dementia and Geriatric Cognitive Disorders·Josefine AndinJan Marcusson
Jun 28, 2005·Nucleic Acids Research·Dina Schneidman-DuhovnyHaim J Wolfson
Dec 31, 2005·Nucleic Acids Research·David S WishartJennifer Woolsey
Feb 17, 2007·Neuroscience Letters·Berthold LangguthPeter Eichhammer
Mar 8, 2007·Nature Clinical Practice. Neurology·Kalluri Subba Rao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2021 Meta ULC. All rights reserved